Filter Results :

Your search for Obesity returned 35 reports

Sort by


Anti-Obesity Drugs Industry Forecasts - China Focus

15 May 2017  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China’s Anti-Obesity Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one o...

$ 1,800.00

Read More

Anti-Obesity Drugs Companies in China

15 May 2017  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China’s Anti-Obesity Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and ...

$ 1,800.00

Read More

Anti-Obesity Drugs Markets in China

15 May 2017  |  Published by:  Asia Market Info and Dev Co.
China's demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, c...

$ 4,000.00

Read More

Global Obesity Surgery Devices Sales Market Report 2017

10 May 2017  |  Published by:  QYResearch
In this report, the global Obesity Surgery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report split global into several key Regions, with sales (Units), revenue (Mil...

$ 4,000.00

Read More

Sugar: The Fool Proof Target for Obesity or a Can of Worms?

10 Apr 2017  |  Published by:  Euromonitor
Sugar continues to have a bad reputation, but globally its consumption is still growing. As developing countries are increasingly becoming dependent on high-sugar packaged foods and soft drinks, they will see significant growth in sugar purchasing. On the other hand, increasing awareness of sugar co...

$ 1,325.00

Read More

Global Obesity Partnering 2010 to 2017

01 Apr 2017  |  Published by:  CurrentPartnering
The Global Obesity Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry secto...

$ 1,495.00

Read More

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025

06 Mar 2017  |  Published by:  MarketsandMarkets
The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025). Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and ...

$ 5,650.00

Read More

Abdominal Obesity Global Clinical Trials Review, H1, 2017

22 Feb 2017  |  Published by:  GlobalData
Summary'Abdominal Obesity Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Obesity. Report includes an overview of trial numbers and their average enrollment in...

$ 2,500.00

Read More

China Anti-Obesity Drugs Market Research Report 2017

21 Feb 2017  |  Published by:  QYResearch
Notes:Sales, means the sales volume of Anti-Obesity DrugsRevenue, means the sales value of Anti-Obesity DrugsThis report studies Anti-Obesity Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering ...

$ 3,200.00

Read More

Europe Anti-Obesity Drugs Market Report 2017

14 Feb 2017  |  Published by:  QYResearch
Notes:Sales, means the sales volume of Anti-Obesity DrugsRevenue, means the sales value of Anti-Obesity DrugsThis report studies sales (consumption) of Anti-Obesity Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries,...

$ 3,900.00

Read More

Abdominal Obesity-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Abdominal Obesity-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Abdominal Obesity. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phas...

$ 1,250.00

Read More

Obesity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Obesity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Obesity Report is to understand the market and pipeline ...

$ 2,000.00

Read More

Obesity-API Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API ...

$ 1,250.00

Read More

Diabetes & Obesity Drug Development Pipeline Review, 2016

01 Dec 2016  |  Published by:  GBI Research
SummaryThe diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the majority of the pipeline, in terms of both quantity and quality of products, is attributable to these indications. While p...

$ 3,995.00

Read More

Obesity - Pipeline Review, H2 2016

09 Nov 2016  |  Published by:  Global Markets Direct
SummaryObesity - Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The pr...

$ 2,500.00

Read More
Total 35 records.